ARCHIVES

NCI advisors approve recompetition of $62 million phase II contracts program.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

Cyramza Combination Approved In Advanced Gastric Cancer

November 28, 2014

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Senate Approves Supplemental Funds For NIH and FDA.

May 23, 2008

NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01

June 21, 1991

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006